New federal price controls could hurt launch of new drugs
By
The IJ Staff
|
Feb. 4, 2020, 11:08 a.m.
Photo: Unsplash
Ottawa’s new price controls for patented medicines in Canada are causing delayed product launches and a loss of jobs in the pharmaceutical industry, according to a survey of senior executives conducted for Life Sciences Ontario.
This article is reserved to PRO Level subscribers
Discover the PRO Level
Already subscribed? Sign in >
Advertisement
The most popular in Health
Make your business shine with Visibility360!
Get a PDF version to share in your networks.
I'm interestedHeadlines
Advertisement
Related topics …